Cell Division Cycle 5-Like (CDC5L), a regulator of the G2/M transition in the cell cycle, has demonstrated potential oncogenic activity in colorectal tumors, bladder cancer, cervical tumors, and osteosarcoma 39-42. Here, CDC5L is linked to urinary bladder cancer.